FIELD: biotechnology.
SUBSTANCE: invention relates to genetic engineering, particularly, to screening of substances having weight control effect, and can be used in medicine. Method of screening substances having weight control effect, involves bringing test substance into contact with cells expressing Synoviolin gene, and identifying whether above test substance has or not inhibiting effect on Synoviolin gene expression. Pharmaceutical compositions include nucleic acid, which suppresses Synoviolin gene expression, or Synoviolin protein ubiquitinylation activity inhibitor.
EFFECT: invention makes it possible to effect on weight reduction by inhibition of gene expression or Synoviolin protein activity.
4 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NON-HUMAN ANIMALS WITH A GYRATE DEFICIENCY | 2014 |
|
RU2721855C2 |
| RODENTS WITH CONDITIONAL ACVR1 MUTANT ALLELES | 2014 |
|
RU2676961C2 |
| MODEL OF PROGRESSIVE OSSIFICATION FIBRODYSPLASIYA IN RODENTS | 2019 |
|
RU2795136C2 |
| METHOD FOR OBTAINING ANIMAL BEING DISTINCT AGAINST A MAN WITH A CERTAIN MUTATED GENE, METHOD FOR TESTING SUBSTANCE TO BE APPLIED FOR TREATING ALZHEIMER'S DISEASE (VARIANTS), PLASMID (VARIANTS), METHOD FOR OBTAINING PRIMARY CELL CULTURE OR SUBCULTIVATED CELL | 1999 |
|
RU2266002C2 |
| OBESITY POLYPEPTIDE (OB) (VARIANTS), ITS ANALOGUE (VARIANTS), AND FUSED PROTEIN (VARIANTS), NUCLEIC ACID ISOLATED MOLECULE, DNA MOLECULE, CLONING RECOMBINANT VECTOR, EXPRESSION RECOMBINANT VECTOR, PHARMACEUTICAL COMPOSITION, MONOCLONAL AND POLYCLONAL ANTIBODY | 1995 |
|
RU2273645C9 |
| ANIMALS WITH HUMANIZED IL-4 AND IL-4Rα | 2015 |
|
RU2703139C2 |
| HUMANISED MICE WITH SIRPA-IL15 NOKIN AND METHODS FOR USING THEM | 2016 |
|
RU2730599C2 |
| ANIMALS WITH HUMANIZED IL-4 AND IL-4Rα | 2015 |
|
RU2788523C2 |
| HUMANIZED T-CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS | 2016 |
|
RU2732628C2 |
| NON-HUMAN ANIMALS HAVING A HUMANIZED PROLIFERATION-INDUCING LIGAND GENE | 2014 |
|
RU2671101C1 |
